Project
Identifying new therapeutic approaches targeting ErbB receptor family for melanoma patients with resistance to immunotherapy - a major unmet need
Ongoing ยท 2023 until 2025
Flatz Lukas
Type
Fundamental Research
Units
Status
Ongoing
Start Date
2023
End Date
2025
Financing
Krebsliga Switzerland